Susan L. Cohn to Recombinant Proteins
This is a "connection" page, showing publications Susan L. Cohn has written about Recombinant Proteins.
Connection Strength
0.042
-
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. Clin Cancer Res. 2021 04 15; 27(8):2179-2189.
Score: 0.042